><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>CF</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name><name><surname>Kuchroo</surname><given-names>VJ</given-names></name><name><surname>Sacks</surname><given-names>D</given-names></name></person-group><article-title>CD4(+) CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis</article-title><source>J Exp Med</source><year>2007</year><volume>204</volume><fpage>285</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">17283207</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Gigliotti Rothfuchs</surname><given-names>A</given-names></name><name><surname>Gonc&#x000e7;alves</surname><given-names>R</given-names></name><name><surname>Roff&#x000ea;</surname><given-names>E</given-names></name><name><surname>Cheever</surname><given-names>AW</given-names></name><name><surname>Bafica</surname><given-names>A</given-names></name><name><surname>Salazar</surname><given-names>AM</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><article-title>Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population</article-title><source>J Clin Invest</source><year>2010</year><volume>120</volume><fpage>1674</fpage><lpage>1682</lpage><pub-id pub-id-type="pmid">20389020</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arimori</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>R</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>N</given-names></name><name><surname>Kase</surname><given-names>T</given-names></name><name><surname>Yoshikai</surname><given-names>Y</given-names></name></person-group><article-title>Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice</article-title><source>Antiviral Res</source><year>2013</year><volume>4</volume><fpage>230</fpage><lpage>237</lpage></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbuch</surname><given-names>V</given-names></name><name><surname>Brockstedt</surname><given-names>DG</given-names></name><name><surname>Meyer-Morse</surname><given-names>N</given-names></name><name><surname>O&#x02019;Riordan</surname><given-names>M</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group><article-title>Mice lacking the type I interferon receptor are resistant to <italic>Listeria</italic> monocytogenes</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>527</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">15302899</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Rouse</surname><given-names>BT</given-names></name></person-group><article-title>Natural regulatory T cells in infectious disease</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">15785761</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Banchereau</surname><given-names>R</given-names></name><name><surname>Skinner</surname><given-names>J</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettelli</surname><given-names>E</given-names></name><name><surname>Carrier</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Korn</surname><given-names>T</given-names></name><name><surname>Strom</surname><given-names>TB</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name><name><surname>Weiner</surname><given-names>HL</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group><article-title>Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>235</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">16648838</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boussiotis</surname><given-names>VA</given-names></name><name><surname>Tsai</surname><given-names>EY</given-names></name><name><surname>Yunis</surname><given-names>EJ</given-names></name><name><surname>Thim</surname><given-names>S</given-names></name><name><surname>Delgado</surname><given-names>JC</given-names></name><name><surname>Dascher</surname><given-names>CC</given-names></name><name><surname>Berezovskaya</surname><given-names>A</given-names></name><name><surname>Rousset</surname><given-names>D</given-names></name><name><surname>Reynes</surname><given-names>JM</given-names></name><name><surname>Goldfeld</surname><given-names>AE</given-names></name></person-group><article-title>IL-10-producing T cells suppress immune responses in anergic tuberculosis patients</article-title><source>J Clin Invest</source><year>2000</year><volume>105</volume><fpage>1317</fpage><lpage>1325</lpage><pub-id pub-id-type="pmid">10792007</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>MJ</given-names></name><name><surname>Jagannathan</surname><given-names>P</given-names></name><name><surname>Farrington</surname><given-names>LA</given-names></name><name><surname>Eccles-James</surname><given-names>I</given-names></name><name><surname>Wamala</surname><given-names>S</given-names></name><name><surname>McIntyre</surname><given-names>TI</given-names></name><name><surname>Vance</surname><given-names>HM</given-names></name><name><surname>Bowen</surname><given-names>K</given-names></name><name><surname>Nankya</surname><given-names>F</given-names></name><name><surname>Auma</surname><given-names>A</given-names></name><etal/></person-group><article-title>Decline of FoxP3+ regulatory CD4 T cells in peripheral blood of children heavily exposed to malaria</article-title><source>PLoS Pathog</source><year>2015</year><volume>11</volume><fpage>e1005041</fpage><pub-id pub-id-type="pmid">26182204</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>NS</given-names></name><name><surname>Moebius</surname><given-names>J</given-names></name><name><surname>Pewe</surname><given-names>LL</given-names></name><name><surname>Traore</surname><given-names>B</given-names></name><name><surname>Doumbo</surname><given-names>OK</given-names></name><name><surname>Tygrett</surname><given-names>LT</given-names></name><name><surname>Waldschmidt</surname><given-names>TJ</given-names></name><name><surname>Crompton</surname><given-names>PD</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><article-title>Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage <italic>Plasmodium</italic> infection</article-title><source>Nat Immunol</source><year>2011</year><volume>13</volume><fpage>188</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">22157630</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camisaschi</surname><given-names>C</given-names></name><name><surname>Casati</surname><given-names>C</given-names></name><name><surname>Rini</surname><given-names>F</given-names></name><name><surname>Perego</surname><given-names>M</given-names></name><name><surname>De Filippo</surname><given-names>A</given-names></name><name><surname>Triebel</surname><given-names>F</given-names></name><name><surname>Parmiani</surname><given-names>G</given-names></name><name><surname>Belli</surname><given-names>F</given-names></name><name><surname>Rivoltini</surname><given-names>L</given-names></name><name><surname>Castelli</surname><given-names>C</given-names></name></person-group><article-title>LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><fpage>6545</fpage><lpage>6551</lpage><pub-id pub-id-type="pmid">20421648</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>JA</given-names></name><name><surname>Calderon</surname><given-names>B</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group><article-title>Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to <italic>Listeria</italic> infection</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">15302900</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname><given-names>A</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name></person-group><article-title>Control of inflammation by integration of environmental cues by regulatory T cells</article-title><source>J Clin Invest</source><year>2013</year><volume>123</volume><fpage>939</fpage><lpage>944</lpage><pub-id pub-id-type="pmid">23454755</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christiaansen</surname><given-names>AF</given-names></name><name><surname>Knudson</surname><given-names>CJ</given-names></name><name><surname>Weiss</surname><given-names>KA</given-names></name><name><surname>Varga</surname><given-names>SM</given-names></name></person-group><article-title>The CD4 T cell response to respiratory syncytial virus infection</article-title><source>Immunol Res</source><year>2014</year><volume>59</volume><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">24838148</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>CL</given-names></name><name><surname>Brown</surname><given-names>G</given-names></name><name><surname>Hamilton</surname><given-names>JA</given-names></name><name><surname>Rogerson</surname><given-names>S</given-names></name><name><surname>Boeuf</surname><given-names>P</given-names></name></person-group><article-title>Monocytes and macrophages in malaria: protection or pathology?</article-title><source>Trends Parasitol</source><year>2013</year><volume>29</volume><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">23142189</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>PA</given-names></name><name><surname>Leoratti</surname><given-names>FM</given-names></name><name><surname>Figueiredo</surname><given-names>MM</given-names></name><name><surname>Tada</surname><given-names>MS</given-names></name><name><surname>Pereira</surname><given-names>DB</given-names></name><name><surname>Junqueira</surname><given-names>C</given-names></name><name><surname>Soares</surname><given-names>IS</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Gazzinelli</surname><given-names>RT</given-names></name><name><surname>Antonelli</surname><given-names>LR</given-names></name></person-group><article-title>Induction of inhibitory receptors on T cells during <italic>Plasmodium vivax</italic> malaria impairs cytokine production</article-title><source>J Infect Dis</source><year>2015</year><volume>212</volume><fpage>1999</fpage><lpage>2010</lpage><pub-id pub-id-type="pmid">26019284</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couper</surname><given-names>KN</given-names></name><name><surname>Blount</surname><given-names>DG</given-names></name><name><surname>Wilson</surname><given-names>MS</given-names></name><name><surname>Hafalla</surname><given-names>JC</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Kamanaka</surname><given-names>M</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>de Souza</surname><given-names>JB</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name></person-group><article-title>IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000004</fpage><pub-id pub-id-type="pmid">18401464</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currier</surname><given-names>J</given-names></name><name><surname>Beck</surname><given-names>HP</given-names></name><name><surname>Currie</surname><given-names>B</given-names></name><name><surname>Good</surname><given-names>MF</given-names></name></person-group><article-title>Antigens released at schizont burst stimulate <italic>Plasmodium falciparum</italic>-specific CD4+ T cells from non-exposed donors: potential for cross-reactive memory T cells to cause disease</article-title><source>Int Immunol</source><year>1995</year><volume>7</volume><fpage>821</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">7547708</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L</given-names></name><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group><article-title>Dynamic roles of type I and type II IFNs in early infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>J Immunol</source><year>2012</year><volume>188</volume><fpage>6205</fpage><lpage>6215</lpage><pub-id pub-id-type="pmid">22566567</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engwerda</surname><given-names>CR</given-names></name><name><surname>Ng</surname><given-names>SS</given-names></name><name><surname>Bunn</surname><given-names>PT</given-names></name></person-group><article-title>The regulation of CD4(+) T cell responses during protozoan infections</article-title><source>Front Immunol</source><year>2014</year><volume>5</volume><fpage>498</fpage><pub-id pub-id-type="pmid">25352846</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Good</surname><given-names>MF</given-names></name></person-group><article-title>Immunological responses from non-exposed donors to malaria antigens: implications for immunity and pathology</article-title><source>Immunol Lett</source><year>1994</year><volume>41</volume><fpage>123</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">8002027</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>SJ</given-names></name><name><surname>West</surname><given-names>EE</given-names></name><name><surname>Araki</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><article-title>Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections</article-title><source>Immunol Rev</source><year>2008</year><volume>223</volume><fpage>317</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">18613845</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafalla</surname><given-names>JC</given-names></name><name><surname>Claser</surname><given-names>C</given-names></name><name><surname>Couper</surname><given-names>KN</given-names></name><name><surname>Grau</surname><given-names>GE</given-names></name><name><surname>Renia</surname><given-names>L</given-names></name><name><surname>de Souza</surname><given-names>JB</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name></person-group><article-title>The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to <italic>Plasmodium</italic>-induced acute immune pathology</article-title><source>PLoS Pathog</source><year>2012</year><volume>8</volume><fpage>e1002504</fpage><pub-id pub-id-type="pmid">22319445</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>A</given-names></name><name><surname>Best</surname><given-names>SE</given-names></name><name><surname>Ammerdorffer</surname><given-names>A</given-names></name><name><surname>Desbarrieres</surname><given-names>L</given-names></name><name><surname>de Oca</surname><given-names>MM</given-names></name><name><surname>Amante</surname><given-names>FH</given-names></name><name><surname>de Labastida Rivera</surname><given-names>F</given-names></name><name><surname>Hertzog</surname><given-names>P</given-names></name><name><surname>Boyle</surname><given-names>GM</given-names></name><name><surname>Hill</surname><given-names>GR</given-names></name><name><surname>Engwerda</surname><given-names>CR</given-names></name></person-group><article-title>Type I interferons suppress CD4<sup>+</sup> T-cell-dependent parasite control during blood-stage <italic>Plasmodium</italic> infection</article-title><source>Eur J Immunol</source><year>2011</year><volume>41</volume><fpage>2688</fpage><lpage>2698</lpage><pub-id pub-id-type="pmid">21674481</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>A</given-names></name><name><surname>Best</surname><given-names>SE</given-names></name><name><surname>Montes de Oca</surname><given-names>M</given-names></name><name><surname>James</surname><given-names>KR</given-names></name><name><surname>Ammerdorffer</surname><given-names>A</given-names></name><name><surname>Edwards</surname><given-names>CL</given-names></name><name><surname>de Labastida Rivera</surname><given-names>F</given-names></name><name><surname>Amante</surname><given-names>FH</given-names></name><name><surname>Bunn</surname><given-names>PT</given-names></name><name><surname>Sheel</surname><given-names>M</given-names></name><etal/></person-group><article-title>Type I IFN signaling in CD8-DCs impairs Th1-dependent malaria immunity</article-title><source>J Clin Invest</source><year>2014</year><volume>124</volume><fpage>2483</fpage><lpage>2496</lpage><pub-id pub-id-type="pmid">24789914</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>F</given-names></name></person-group><article-title>Expression of Tim-1 and Tim-3 in <italic>Plasmodium berghei</italic> ANKA infection</article-title><source>Parasitol Res</source><year>2013</year><volume>112</volume><fpage>2713</fpage><lpage>2719</lpage><pub-id pub-id-type="pmid">23653017</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illingworth</surname><given-names>J</given-names></name><name><surname>Butler</surname><given-names>NS</given-names></name><name><surname>Roetynck</surname><given-names>S</given-names></name><name><surname>Mwacharo</surname><given-names>J</given-names></name><name><surname>Pierce</surname><given-names>SK</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Crompton</surname><given-names>PD</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Ndungu</surname><given-names>FM</given-names></name></person-group><article-title>Chronic exposure to <italic>Plasmodium falciparum</italic> is associated with phenotypic evidence of B and T cell exhaustion</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><fpage>1038</fpage><lpage>1047</lpage><pub-id pub-id-type="pmid">23264654</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>T</given-names></name><name><surname>Graefe</surname><given-names>SE</given-names></name><name><surname>Niknafs</surname><given-names>S</given-names></name><name><surname>Gaworski</surname><given-names>I</given-names></name><name><surname>Fleischer</surname><given-names>B</given-names></name></person-group><article-title>Murine malaria is exacerbated by CTLA-4 blockade</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>2323</fpage><lpage>2329</lpage><pub-id pub-id-type="pmid">12193697</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagannathan</surname><given-names>P</given-names></name><name><surname>Eccles-James</surname><given-names>I</given-names></name><name><surname>Bowen</surname><given-names>K</given-names></name><name><surname>Nankya</surname><given-names>F</given-names></name><name><surname>Auma</surname><given-names>A</given-names></name><name><surname>Wamala</surname><given-names>S</given-names></name><name><surname>Ebusu</surname><given-names>C</given-names></name><name><surname>Muhindo</surname><given-names>MK</given-names></name><name><surname>Arinaitwe</surname><given-names>E</given-names></name><name><surname>Briggs</surname><given-names>J</given-names></name><etal/></person-group><article-title>IFN&#x003b3;/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><fpage>e1003864</fpage><pub-id pub-id-type="pmid">24415936</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>D</given-names></name><name><surname>Kullberg</surname><given-names>MC</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Goldszmid</surname><given-names>RS</given-names></name><name><surname>Collazo</surname><given-names>CM</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Kamanaka</surname><given-names>M</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><article-title>Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection</article-title><source>J Exp Med</source><year>2007</year><volume>204</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">17283209</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>D</given-names></name><name><surname>Kugler</surname><given-names>DG</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><article-title>IL-10 production by CD4+ effector T cells: a mechanism for self-regulation</article-title><source>Mucosal Immunol</source><year>2010</year><volume>3</volume><fpage>239</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">20200511</pub-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>HT</given-names></name><name><surname>Anderson</surname><given-names>AC</given-names></name><name><surname>Tan</surname><given-names>WG</given-names></name><name><surname>West</surname><given-names>EE</given-names></name><name><surname>Ha</surname><given-names>SJ</given-names></name><name><surname>Araki</surname><given-names>K</given-names></name><name><surname>Freeman</surname><given-names>GJ</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><article-title>Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>14733</fpage><lpage>14738</lpage><pub-id pub-id-type="pmid">20679213</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karyana</surname><given-names>M</given-names></name><name><surname>Burdarm</surname><given-names>L</given-names></name><name><surname>Yeung</surname><given-names>S</given-names></name><name><surname>Kenangalem</surname><given-names>E</given-names></name><name><surname>Wariker</surname><given-names>N</given-names></name><name><surname>Maristela</surname><given-names>R</given-names></name><name><surname>Umana</surname><given-names>KG</given-names></name><name><surname>Vemuri</surname><given-names>R</given-names></name><name><surname>Okoseray</surname><given-names>MJ</given-names></name><name><surname>Penttinen</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Malaria morbidity in Papua Indonesia, an area with multidrug resistant <italic>Plasmodium vivax</italic> and <italic>Plasmodium falciparum</italic></article-title><source>Malar J</source><year>2008</year><volume>7</volume><fpage>148</fpage><pub-id pub-id-type="pmid">18673572</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kester</surname><given-names>KE</given-names></name><name><surname>Cummings</surname><given-names>JF</given-names></name><name><surname>Ofori-Anyinam</surname><given-names>O</given-names></name><name><surname>Ockenhouse</surname><given-names>CF</given-names></name><name><surname>Krzych</surname><given-names>U</given-names></name><name><surname>Moris</surname><given-names>P</given-names></name><name><surname>Schwenk</surname><given-names>R</given-names></name><name><surname>Nielsen</surname><given-names>RA</given-names></name><name><surname>Debebe</surname><given-names>Z</given-names></name><name><surname>Pinelis</surname><given-names>E</given-names></name><etal/><collab>RTS,S Vaccine Evaluation Group</collab></person-group><article-title>Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection</article-title><source>J Infect Dis</source><year>2009</year><volume>200</volume><fpage>337</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">19569965</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangan</surname><given-names>PR</given-names></name><name><surname>Harrington</surname><given-names>LE</given-names></name><name><surname>O&#x02019;Quinn</surname><given-names>DB</given-names></name><name><surname>Helms</surname><given-names>WS</given-names></name><name><surname>Bullard</surname><given-names>DC</given-names></name><name><surname>Elson</surname><given-names>CO</given-names></name><name><surname>Hatton</surname><given-names>RD</given-names></name><name><surname>Wahl</surname><given-names>SM</given-names></name><name><surname>Schoeb</surname><given-names>TR</given-names></name><name><surname>Weaver</surname><given-names>CT</given-names></name></person-group><article-title>Transforming growth factor-beta induces development of the T(H)17 lineage</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>231</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">16648837</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><name><surname>Oland</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><article-title>Innate and adaptive interferons suppress IL-1&#x003b1; and IL-1&#x003b2; production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>1023</fpage><lpage>1034</lpage><pub-id pub-id-type="pmid">22195750</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCall</surname><given-names>MB</given-names></name><name><surname>Hopman</surname><given-names>J</given-names></name><name><surname>Daou</surname><given-names>M</given-names></name><name><surname>Maiga</surname><given-names>B</given-names></name><name><surname>Dara</surname><given-names>V</given-names></name><name><surname>Ploemen</surname><given-names>I</given-names></name><name><surname>Nganou Makamdop</surname><given-names>K</given-names></name><name><surname>Niangaly</surname><given-names>A</given-names></name><name><surname>Tolo</surname><given-names>Y</given-names></name><name><surname>Arama</surname><given-names>C</given-names></name><etal/></person-group><article-title>Early interferon-gamma response against <italic>Plasmodium falciparum</italic> correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali</article-title><source>J Infect Dis</source><year>2010</year><volume>201</volume><fpage>142</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">19929378</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Ewbank</surname><given-names>J</given-names></name><name><surname>Howes</surname><given-names>A</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><name><surname>Martirosyan</surname><given-names>A</given-names></name><name><surname>Ghilardi</surname><given-names>N</given-names></name><name><surname>Saraiva</surname><given-names>M</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group><article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-&#x003b3; for production of IL-12 and bacterial killing in <italic>Mycobacterium tuberculosis</italic> infected macrophages</article-title><source>J Immunol</source><year>2014</year><volume>193</volume><fpage>3600</fpage><lpage>3612</lpage><pub-id pub-id-type="pmid">25187652</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F</given-names></name><name><surname>Mayer-Barber</surname><given-names>K</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group><article-title>Type I interferons in infectious disease</article-title><source>Nat Rev Immunol</source><year>2015</year><volume>15</volume><fpage>87</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">25614319</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meding</surname><given-names>SJ</given-names></name><name><surname>Cheng</surname><given-names>SC</given-names></name><name><surname>Simon-Haarhaus</surname><given-names>B</given-names></name><name><surname>Langhorne</surname><given-names>J</given-names></name></person-group><article-title>Role of gamma interferon during infection with <italic>Plasmodium chabaudi chabaudi</italic></article-title><source>Infect Immun</source><year>1990</year><volume>58</volume><fpage>3671</fpage><lpage>3678</lpage><pub-id pub-id-type="pmid">1977706</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migueles</surname><given-names>SA</given-names></name><name><surname>Connors</surname><given-names>M</given-names></name></person-group><article-title>Success and failure of the cellular immune response against HIV-1</article-title><source>Nat Immunol</source><year>2015</year><volume>16</volume><fpage>563</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">25988888</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minigo</surname><given-names>G</given-names></name><name><surname>Woodberry</surname><given-names>T</given-names></name><name><surname>Piera</surname><given-names>KA</given-names></name><name><surname>Salwati</surname><given-names>E</given-names></name><name><surname>Tjitra</surname><given-names>E</given-names></name><name><surname>Kenangalem</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>RN</given-names></name><name><surname>Engwerda</surname><given-names>CR</given-names></name><name><surname>Anstey</surname><given-names>NM</given-names></name><name><surname>Plebanski</surname><given-names>M</given-names></name></person-group><article-title>Parasite dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria</article-title><source>PLoS Pathog</source><year>2009</year><volume>5</volume><fpage>e1000402</fpage><pub-id pub-id-type="pmid">19390618</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montes de Oca</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>de Labastida Rivera</surname><given-names>F</given-names></name><name><surname>Amante</surname><given-names>FH</given-names></name><name><surname>Sheel</surname><given-names>M</given-names></name><name><surname>Faleiro</surname><given-names>RJ</given-names></name><name><surname>Bunn</surname><given-names>PT</given-names></name><name><surname>Best</surname><given-names>SE</given-names></name><name><surname>Beattie</surname><given-names>L</given-names></name><name><surname>Ng</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Blimp-1-dependent IL-10 production by Tr1 cells regulates</article-title><source>PLoS Pathog</source><year>2016</year><volume>12</volume><fpage>e1005398</fpage><pub-id pub-id-type="pmid">26765224</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndungu</surname><given-names>FM</given-names></name><name><surname>Sanni</surname><given-names>L</given-names></name><name><surname>Urban</surname><given-names>B</given-names></name><name><surname>Stephens</surname><given-names>R</given-names></name><name><surname>Newbold</surname><given-names>CI</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Langhorne</surname><given-names>J</given-names></name></person-group><article-title>CD4 T cells from malaria-nonexposed individuals respond to the CD36-binding domain of <italic>Plasmodium falciparum</italic> erythrocyte membrane protein-1 via an MHC class II-TCR-independent pathway</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><fpage>5504</fpage><lpage>5512</lpage><pub-id pub-id-type="pmid">16622019</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyl&#x000e9;n</surname><given-names>S</given-names></name><name><surname>Maurya</surname><given-names>R</given-names></name><name><surname>Eidsmo</surname><given-names>L</given-names></name><name><surname>Manandhar</surname><given-names>KD</given-names></name><name><surname>Sundar</surname><given-names>S</given-names></name><name><surname>Sacks</surname><given-names>D</given-names></name></person-group><article-title>Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis</article-title><source>J Exp Med</source><year>2007</year><volume>204</volume><fpage>805</fpage><lpage>817</lpage><pub-id pub-id-type="pmid">17389235</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name><name><surname>Vieira</surname><given-names>PL</given-names></name><name><surname>Vieira</surname><given-names>P</given-names></name><name><surname>Goldfeld</surname><given-names>AE</given-names></name></person-group><article-title>IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage</article-title><source>J Clin Invest</source><year>2004</year><volume>114</volume><fpage>1372</fpage><lpage>1378</lpage><pub-id pub-id-type="pmid">15545984</pub-id></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ockenhouse</surname><given-names>CF</given-names></name><name><surname>Regules</surname><given-names>J</given-names></name><name><surname>Tosh</surname><given-names>D</given-names></name><name><surname>Cowden</surname><given-names>J</given-names></name><name><surname>Kathcart</surname><given-names>A</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Paolino</surname><given-names>K</given-names></name><name><surname>Moon</surname><given-names>J</given-names></name><name><surname>Komisar</surname><given-names>J</given-names></name><name><surname>Kamau</surname><given-names>E</given-names></name><etal/></person-group><article-title>Ad35.CS.01-RTS,S/AS01 heterologous prime boost vaccine efficacy against sporozoite challenge in healthy malaria-na&#x000ef;ve adults</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0131571</fpage><pub-id pub-id-type="pmid">26148007</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omer</surname><given-names>FM</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name></person-group><article-title>Transforming growth factor beta production is inversely correlated with severity of murine malaria infection</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">9653082</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> induces type I IFN signaling in dendritic cells via TLR9</article-title><source>J Immunol</source><year>2012</year><volume>189</volume><fpage>4040</fpage><lpage>4046</lpage><pub-id pub-id-type="pmid">22962685</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitt</surname><given-names>JM</given-names></name><name><surname>Blankley</surname><given-names>S</given-names></name><name><surname>McShane</surname><given-names>H</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group><article-title>Vaccination against tuberculosis: how can we better BCG?</article-title><source>Microb Pathog</source><year>2013</year><volume>58</volume><fpage>2</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">23257069</pub-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plebanski</surname><given-names>M</given-names></name><name><surname>Flanagan</surname><given-names>KL</given-names></name><name><surname>Lee</surname><given-names>EA</given-names></name><name><surname>Reece</surname><given-names>WH</given-names></name><name><surname>Hart</surname><given-names>K</given-names></name><name><surname>Gelder</surname><given-names>C</given-names></name><name><surname>Gillespie</surname><given-names>G</given-names></name><name><surname>Pinder</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>AV</given-names></name></person-group><article-title>Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of <italic>Plasmodium falciparum</italic></article-title><source>Immunity</source><year>1999</year><volume>10</volume><fpage>651</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">10403640</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polhemus</surname><given-names>ME</given-names></name><name><surname>Remich</surname><given-names>SA</given-names></name><name><surname>Ogutu</surname><given-names>BR</given-names></name><name><surname>Waitumbi</surname><given-names>JN</given-names></name><name><surname>Otieno</surname><given-names>L</given-names></name><name><surname>Apollo</surname><given-names>S</given-names></name><name><surname>Cummings</surname><given-names>JF</given-names></name><name><surname>Kester</surname><given-names>KE</given-names></name><name><surname>Ockenhouse</surname><given-names>CF</given-names></name><name><surname>Stewart</surname><given-names>A</given-names></name><etal/></person-group><article-title>Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><fpage>e6465</fpage><pub-id pub-id-type="pmid">19649245</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portugal</surname><given-names>S</given-names></name><name><surname>Moebius</surname><given-names>J</given-names></name><name><surname>Skinner</surname><given-names>J</given-names></name><name><surname>Doumbo</surname><given-names>S</given-names></name><name><surname>Doumtabe</surname><given-names>D</given-names></name><name><surname>Kone</surname><given-names>Y</given-names></name><name><surname>Dia</surname><given-names>S</given-names></name><name><surname>Kanakabandi</surname><given-names>K</given-names></name><name><surname>Sturdevant</surname><given-names>DE</given-names></name><name><surname>Virtaneva</surname><given-names>K</given-names></name><etal/></person-group><article-title>Exposure-dependent control of malaria-induced inflammation in children</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><fpage>e1004079</fpage><pub-id pub-id-type="pmid">24743880</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratcliff</surname><given-names>A</given-names></name><name><surname>Siswantoro</surname><given-names>H</given-names></name><name><surname>Kenangalem</surname><given-names>E</given-names></name><name><surname>Maristela</surname><given-names>R</given-names></name><name><surname>Wuwung</surname><given-names>RM</given-names></name><name><surname>Laihad</surname><given-names>F</given-names></name><name><surname>Ebsworth</surname><given-names>EP</given-names></name><name><surname>Anstey</surname><given-names>NM</given-names></name><name><surname>Tjitra</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>RN</given-names></name></person-group><article-title>Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison</article-title><source>Lancet</source><year>2007</year><volume>369</volume><fpage>757</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">17336652</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockett</surname><given-names>RJ</given-names></name><name><surname>Tozer</surname><given-names>SJ</given-names></name><name><surname>Peatey</surname><given-names>C</given-names></name><name><surname>Bialasiewicz</surname><given-names>S</given-names></name><name><surname>Whiley</surname><given-names>DM</given-names></name><name><surname>Nissen</surname><given-names>MD</given-names></name><name><surname>Trenholme</surname><given-names>K</given-names></name><name><surname>Mc Carthy</surname><given-names>JS</given-names></name><name><surname>Sloots</surname><given-names>TP</given-names></name></person-group><article-title>A real-time, quantitative PCR method using hydrolysis probes for the monitoring of <italic>Plasmodium falciparum</italic> load in experimentally infected human volunteers</article-title><source>Malar J</source><year>2011</year><volume>10</volume><fpage>48</fpage><pub-id pub-id-type="pmid">21352599</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-Garc&#x000ed;a</surname><given-names>M</given-names></name><name><surname>Porichis</surname><given-names>F</given-names></name><name><surname>de Jong</surname><given-names>OG</given-names></name><name><surname>Levi</surname><given-names>K</given-names></name><name><surname>Diefenbach</surname><given-names>TJ</given-names></name><name><surname>Lifson</surname><given-names>JD</given-names></name><name><surname>Freeman</surname><given-names>GJ</given-names></name><name><surname>Walker</surname><given-names>BD</given-names></name><name><surname>Kaufmann</surname><given-names>DE</given-names></name><name><surname>Kavanagh</surname><given-names>DG</given-names></name></person-group><article-title>Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10</article-title><source>J Leukoc Biol</source><year>2011</year><volume>89</volume><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">21097698</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><collab>Rts, S.C.T.P.; RTS,S Clinical Trials Partnership</collab><article-title>Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial</article-title><source>Lancet</source><year>2015</year><volume>386</volume><fpage>31</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">25913272</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>DL</given-names></name></person-group><article-title>Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem</article-title><source>Nat Immunol</source><year>2014</year><volume>15</volume><fpage>403</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">24747701</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name></person-group><article-title>Regulatory T cells and immune tolerance</article-title><source>Cell</source><year>2008</year><volume>133</volume><fpage>775</fpage><lpage>787</lpage><pub-id pub-id-type="pmid">18510923</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Vignali</surname><given-names>DA</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name><name><surname>Niec</surname><given-names>RE</given-names></name><name><surname>Waldmann</surname><given-names>H</given-names></name></person-group><article-title>The plasticity and stability of regulatory T cells</article-title><source>Nat Rev Immunol</source><year>2013</year><volume>13</volume><fpage>461</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">23681097</pub-id></element-citation></ref><ref id="R61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraiva</surname><given-names>M</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group><article-title>The regulation of IL-10 production by immune cells</article-title><source>Nat Rev Immunol</source><year>2010</year><volume>10</volume><fpage>170</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">20154735</pub-id></element-citation></ref><ref id="R62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlotmann</surname><given-names>T</given-names></name><name><surname>Waase</surname><given-names>I</given-names></name><name><surname>J&#x000fc;lch</surname><given-names>C</given-names></name><name><surname>Klauenberg</surname><given-names>U</given-names></name><name><surname>M&#x000fc;ller-Myhsok</surname><given-names>B</given-names></name><name><surname>Dietrich</surname><given-names>M</given-names></name><name><surname>Fleischer</surname><given-names>B</given-names></name><name><surname>Br&#x000f6;ker</surname><given-names>BM</given-names></name></person-group><article-title>CD4 alphabeta T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria</article-title><source>J Infect Dis</source><year>2000</year><volume>182</volume><fpage>367</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">10882627</pub-id></element-citation></ref><ref id="R63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>DeOliveira</surname><given-names>RB</given-names></name><name><surname>Kalantari</surname><given-names>P</given-names></name><name><surname>Parroche</surname><given-names>P</given-names></name><name><surname>Goutagny</surname><given-names>N</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Bartholomeu</surname><given-names>DC</given-names></name><name><surname>Lauw</surname><given-names>F</given-names></name><name><surname>Hall</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Innate immune recognition of an AT-rich stem-loop DNA motif in the <italic>Plasmodium falciparum</italic> genome</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>194</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">21820332</pub-id></element-citation></ref><ref id="R64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shear</surname><given-names>HL</given-names></name><name><surname>Srinivasan</surname><given-names>R</given-names></name><name><surname>Nolan</surname><given-names>T</given-names></name><name><surname>Ng</surname><given-names>C</given-names></name></person-group><article-title>Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts</article-title><source>J Immunol</source><year>1989</year><volume>143</volume><fpage>2038</fpage><lpage>2044</lpage><pub-id pub-id-type="pmid">2506274</pub-id></element-citation></ref><ref id="R65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheel</surname><given-names>M</given-names></name><name><surname>Engwerda</surname><given-names>CR</given-names></name></person-group><article-title>The diverse roles of monocytes in inflammation caused by protozoan parasitic diseases</article-title><source>Trends Parasitol</source><year>2012</year><volume>28</volume><fpage>408</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">22951424</pub-id></element-citation></ref><ref id="R66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skeiky</surname><given-names>YA</given-names></name><name><surname>Sadoff</surname><given-names>JC</given-names></name></person-group><article-title>Advances in tuberculosis vaccine strategies</article-title><source>Nat Rev Microbiol</source><year>2006</year><volume>4</volume><fpage>469</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">16710326</pub-id></element-citation></ref><ref id="R67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname><given-names>PJ</given-names></name><name><surname>Jarra</surname><given-names>W</given-names></name><name><surname>L&#x000e9;vy</surname><given-names>P</given-names></name><name><surname>Reid</surname><given-names>AJ</given-names></name><name><surname>Chappell</surname><given-names>L</given-names></name><name><surname>Brugat</surname><given-names>T</given-names></name><name><surname>Sanders</surname><given-names>M</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Langhorne</surname><given-names>J</given-names></name></person-group><article-title>Vector transmission regulates immune control of <italic>Plasmodium</italic> virulence</article-title><source>Nature</source><year>2013</year><volume>498</volume><fpage>228</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">23719378</pub-id></element-citation></ref><ref id="R68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>SA</given-names></name><name><surname>Johndrow</surname><given-names>JE</given-names></name><name><surname>Manzanillo</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group><article-title>The type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>3143</fpage><lpage>3152</lpage><pub-id pub-id-type="pmid">17312162</pub-id></element-citation></ref><ref id="R69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>MM</given-names></name><name><surname>Tam</surname><given-names>MF</given-names></name><name><surname>Belosevic</surname><given-names>M</given-names></name><name><surname>van der Meide</surname><given-names>PH</given-names></name><name><surname>Podoba</surname><given-names>JE</given-names></name></person-group><article-title>Role of endogenous gamma interferon in host response to infection with blood-stage <italic>Plasmodium chabaudi</italic></article-title><source>AS Infect Immun</source><year>1990</year><volume>58</volume><fpage>3225</fpage><lpage>3232</lpage><pub-id pub-id-type="pmid">2119342</pub-id></element-citation></ref><ref id="R70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Stevenson</surname><given-names>MM</given-names></name></person-group><article-title>Central role of endogenous gamma interferon in protective immunity against blood-stage <italic>Plasmodium chabaudi</italic> AS infection</article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><fpage>4399</fpage><lpage>4406</lpage><pub-id pub-id-type="pmid">10899836</pub-id></element-citation></ref><ref id="R71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teijaro</surname><given-names>JR</given-names></name><name><surname>Ng</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>AM</given-names></name><name><surname>Sullivan</surname><given-names>BM</given-names></name><name><surname>Sheehan</surname><given-names>KC</given-names></name><name><surname>Welch</surname><given-names>M</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name><name><surname>de la Torre</surname><given-names>JC</given-names></name><name><surname>Oldstone</surname><given-names>MB</given-names></name></person-group><article-title>Persistent LCMV infection is controlled by blockade of type I interferon signaling</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>207</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">23580529</pub-id></element-citation></ref><ref id="R72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>RM</given-names></name><name><surname>Graeber</surname><given-names>TG</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Montoya</surname><given-names>D</given-names></name><name><surname>Schenk</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><name><surname>Komisopoulou</surname><given-names>E</given-names></name><name><surname>Kelly-Scumpia</surname><given-names>K</given-names></name><name><surname>Chun</surname><given-names>R</given-names></name><name><surname>Iyer</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>1448</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">23449998</pub-id></element-citation></ref><ref id="R73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>KJ</given-names></name><name><surname>Villasis</surname><given-names>E</given-names></name><name><surname>Bendez&#x000fa;</surname><given-names>J</given-names></name><name><surname>Chauca</surname><given-names>J</given-names></name><name><surname>Vinetz</surname><given-names>JM</given-names></name><name><surname>Gamboa</surname><given-names>D</given-names></name></person-group><article-title>Relationship of regulatory T cells to <italic>Plasmodium falciparum</italic> malaria symptomatology in a hypoendemic region</article-title><source>Malar J</source><year>2014</year><volume>13</volume><fpage>108</fpage><pub-id pub-id-type="pmid">24642188</pub-id></element-citation></ref><ref id="R74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Heyde</surname><given-names>HC</given-names></name><name><surname>Pepper</surname><given-names>B</given-names></name><name><surname>Batchelder</surname><given-names>J</given-names></name><name><surname>Cigel</surname><given-names>F</given-names></name><name><surname>Weidanz</surname><given-names>WP</given-names></name></person-group><article-title>The time course of selected malarial infections in cytokine-deficient mice</article-title><source>Exp Parasitol</source><year>1997</year><volume>85</volume><fpage>206</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">9030670</pub-id></element-citation></ref><ref id="R75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldhoen</surname><given-names>M</given-names></name><name><surname>Hocking</surname><given-names>RJ</given-names></name><name><surname>Atkins</surname><given-names>CJ</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name><name><surname>Stockinger</surname><given-names>B</given-names></name></person-group><article-title>TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells</article-title><source>Immunity</source><year>2006</year><volume>24</volume><fpage>179</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">16473830</pub-id></element-citation></ref><ref id="R76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>M</given-names></name><name><surname>Tongren</surname><given-names>JE</given-names></name><name><surname>Andrews</surname><given-names>L</given-names></name><name><surname>Korbel</surname><given-names>D</given-names></name><name><surname>King</surname><given-names>E</given-names></name><name><surname>Fletcher</surname><given-names>H</given-names></name><name><surname>Andersen</surname><given-names>RF</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>F</given-names></name><name><surname>Dunachie</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection</article-title><source>Immunity</source><year>2005</year><volume>23</volume><fpage>287</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">16169501</pub-id></element-citation></ref><ref id="R77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>M</given-names></name><name><surname>Jeffries</surname><given-names>D</given-names></name><name><surname>Finney</surname><given-names>OC</given-names></name><name><surname>Njie</surname><given-names>M</given-names></name><name><surname>Ebonyi</surname><given-names>A</given-names></name><name><surname>Deininger</surname><given-names>S</given-names></name><name><surname>Lawrence</surname><given-names>E</given-names></name><name><surname>Ngwa-Amambua</surname><given-names>A</given-names></name><name><surname>Jayasooriya</surname><given-names>S</given-names></name><name><surname>Cheeseman</surname><given-names>IH</given-names></name><etal/></person-group><article-title>Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe <italic>Plasmodium falciparum</italic> malaria</article-title><source>PLoS Pathog</source><year>2009</year><volume>5</volume><fpage>e1000364</fpage><pub-id pub-id-type="pmid">19343213</pub-id></element-citation></ref><ref id="R78"><element-citation publication-type="book"><collab>WHO</collab><source>World Malaria Report 2014</source><year>2014</year><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="R79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>EB</given-names></name><name><surname>Yamada</surname><given-names>DH</given-names></name><name><surname>Elsaesser</surname><given-names>H</given-names></name><name><surname>Herskovitz</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Aronow</surname><given-names>BJ</given-names></name><name><surname>Karp</surname><given-names>CL</given-names></name><name><surname>Brooks</surname><given-names>DG</given-names></name></person-group><article-title>Blockade of chronic type I interferon signaling to control persistent LCMV infection</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>202</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">23580528</pub-id></element-citation></ref><ref id="R80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>L</given-names></name><name><surname>Vargas-Inchaustegui</surname><given-names>DA</given-names></name><name><surname>Raimer</surname><given-names>SS</given-names></name><name><surname>Kelly</surname><given-names>BC</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Soong</surname><given-names>L</given-names></name></person-group><article-title>Type I IFN receptor regulates neutrophil functions and innate immunity to <italic>Leishmania</italic> parasites</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><fpage>7047</fpage><lpage>7056</lpage><pub-id pub-id-type="pmid">20483775</pub-id></element-citation></ref><ref id="R81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoneto</surname><given-names>T</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>CR</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Waki</surname><given-names>S</given-names></name><name><surname>Nariuchi</surname><given-names>H</given-names></name></person-group><article-title>Gamma interferon production is critical for protective immunity to infection with blood-stage <italic>Plasmodium berghei</italic> XAT but neither NO production nor NK cell activation is critical</article-title><source>Infect Immun</source><year>1999</year><volume>67</volume><fpage>2349</fpage><lpage>2356</lpage><pub-id pub-id-type="pmid">10225894</pub-id></element-citation></ref></